Literature DB >> 16314194

Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.

Ludivina Robles-Osorio1, Alejandra Huerta-Zepeda, Ma Luisa Ordóñez, Samuel Canizales-Quinteros, Andrea Díaz-Villaseñor, Ruth Gutiérrez-Aguilar, Laura Riba, Adriana Huertas-Vázquez, Maribel Rodríguez-Torres, Rita A Gómez-Díaz, Saul Salinas, Laura Ongay-Larios, Guadalupe Codiz-Huerta, Minerva Mora-Cabrera, Roopa Mehta, Francisco J Gómez Pérez, Juan A Rull, Jean-Pierre Rabès, Ma Teresa Tusié-Luna, Socorro Durán-Vargas, Carlos A Aguilar-Salinas.   

Abstract

BACKGROUND: Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) are relatively common lipid disorders caused by mutations of the low-density lipoprotein receptor (LDLR) and apolipoprotein B (apoB) genes, respectively. A third locus on chromosome 1p34.1-p32 was recently linked to FH and the responsible gene has been identified [protein convertase subtilisin/kexin type 9 (PCSK9)].
METHODS: We assessed the contribution of the LDLR, apoB, and PCSK9 genes as cause of FH in Mexico. Forty six unrelated probands, as well as 68 affected and 60 healthy relatives, were included.
RESULTS: All index cases were diagnosed as having heterozygous autosomal dominant FH. Seventeen of the 46 index cases had LDLR gene mutations, four of which were novel (Fs92ter108, C268R, Q718X, and Fs736ter743); and only one patient had an apoB mutation (R3500Q). We sequenced the PCSK9 gene in the remainder of the 28 probands with no identified LDLR or APOB gene defects; however, no PCSK9 mutations were found, including one large kindred with positive linkage to the 1p34.1-32 locus (multipoint LOD score of 3.3) and two small pedigrees. Linkage was excluded from these three loci in at least four kindreds suggesting that other yet uncharacterized genes are involved.
CONCLUSIONS: Our results underline substantial genetic heterogeneity for FH in the Mexican population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314194     DOI: 10.1016/j.arcmed.2005.04.018

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  14 in total

1.  Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor.

Authors:  Siham El Aziz; Asma Chadli; Hassan El Ghomari; Ahmed Farouqi
Journal:  BMJ Case Rep       Date:  2012-05-23

2.  Low prevalence of mutations in known loci for autosomal dominant hypercholesterolemia in a multiethnic patient cohort.

Authors:  Zahid Ahmad; Beverley Adams-Huet; Chiyuan Chen; Abhimanyu Garg
Journal:  Circ Cardiovasc Genet       Date:  2012-10-11

Review 3.  Molecular biology of PCSK9: its role in LDL metabolism.

Authors:  Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  Trends Biochem Sci       Date:  2007-01-09       Impact factor: 13.807

4.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

5.  Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene.

Authors:  M T Tejedor; A Cenarro; D Tejedor; M Stef; R Mateo-Gallego; I de Castro; A L García-Otin; L V Monteagudo; F Civeira; M Pocovi
Journal:  Mol Genet Genomics       Date:  2010-04-29       Impact factor: 3.291

Review 6.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

7.  Low allelic heterogeneity in a sample of Mexican patients with classical galactosaemia.

Authors:  J Velázquez-Aragón; M A Alcántara-Ortigoza; M Vela-Amieva; S Monroy; V Martínez-Cruz; C Todd-Quiñones; A González-del Angel
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

8.  Self-association of human PCSK9 correlates with its LDLR-degrading activity.

Authors:  Daping Fan; Patricia G Yancey; Shenfeng Qiu; Lei Ding; Edwin J Weeber; MacRae F Linton; Sergio Fazio
Journal:  Biochemistry       Date:  2008-01-16       Impact factor: 3.162

9.  Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.

Authors:  Awatef Jelassi; Mohamed Najah; Afef Slimani; Imen Jguirim; Mohamed Naceur Slimane; Mathilde Varret
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

10.  Genome-wide linkage scan of a pedigree with familial hypercholesterolemia suggests susceptibility loci on chromosomes 3q25-26 and 21q22.

Authors:  Xu Wang; Xin Li; Yong-Biao Zhang; Feng Zhang; Liyuan Sun; Jie Lin; Duen-Mei Wang; Lu-Ya Wang
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.